Meanwhile, the Aptima SARS-CoV-2 assay, initially granted Emergency Use Authorization status in May 2020, has now achieved ...

In February, Hologic secured the FDA’s 510(k) clearance for the Aptima SARS-CoV-2 assay, building on the Emergency Use Authorization granted in May 2020. Within Cytology and Perinatal ...

Hologic, a medical technology company focused on women's health, provides diagnostic solutions and education to drive improved health outcomes. As the leading provider of cervical cancer testing, the ...

It provides Aptima molecular ... and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. Receive News & Ratings for Hologic Daily - Enter your email ...

It provides Aptima molecular ... and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. Receive News & Ratings for Hologic Daily - Enter your email ...